A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

407

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Multiple Sclerosis
Interventions
DRUG

ONO-4641

0.15 mg once per day for 26 weeks

DRUG

ONO-4641

0.1 mg once per day for 26 weeks

DRUG

ONO-4641

0.05 mg once per day for 26 weeks

DRUG

ONO-4641 placebo

Placebo once per day for 26 weeks

Trial Locations (86)

7100

La Louviere Clinical Site 201, La Louvière

8000

Brugge Clinical Site 203, Bruges

8340

Sijsele Clinical Site 202, Sijsele

11529

Athens Clinical Site 243, Athens

13347

Berlin Clinical Site 223, Berlin

14642

Rochester Clinical Site 108, Rochester

17007

Girona Clinical Site 254, Girona

19104

Philadelphia Clinical Site 120, Philadelphia

21005

Vinnytsya Clinical Site 342, Vinnytsia

27265

HighPoint Clinical Site 128, HighPoint

27607

Raleigh Clinical Site 103, Raleigh

28204

Charlotte Clinical Site 125, Charlotte

32174

Ormond Beach Clinical Site 129, Ormond Beach

34243

Sarasota Clinical Site 116, Sarasota

Sarasota Clinical Site 117, Sarasota

35033

Marburg Clinical Site 228, Marburg

35385

Giessen Clinical Site 221, Giessen

37934

Knoxville Clinical Site 134, Knoxville

41071

Sevilla Clinical Site 256, Seville

44320

Akron Clinical Site 112, Akron

45147

Essen Clinical Site 222, Essen

46202

Indianapolis Clinical Site 121, Indianapolis

46805

Fort Wayne Clinical Site 111, Fort Wayne

48013

Bilbao Clinical Site 255, Bilbao

48149

Munster Clinical Site 225, Münster

48202

Detroit Clinical Site 104, Detroit

48334

Farmington Hills Clinical Site 126, Farmington Hills

49027

Dnipropetrovsk Clinical Site 341, Dnipropetrovsk

55101

Mainz Clinical Site 231, Mainz

57010

Thessaloniki Clinical Site 245, Thessaloniki

60062

Northbrook Clinical Site 135, Northbrook

61068

Kharkiv Clinical Site 346, Kharkiv

72076

Tubingen Clinical Site 226, Tübingen

78681

Round Rock Clinical Site 107, Round Rock

79010

Lviv Clinical Site 343, Lviv

80045

Aurora Clinical Site 132, Aurora

80528

Fort Collins Clinical Site 123, Fort Collins

85741

Tucson Clinical Site 133, Tucson

87131

Albuquerque Clinical Site 106, Albuquerque

89081

Ulm Clinical Site 230, Ulm

98101

Seattle Clinical Site 118, Seattle

107150

Moscow Clinical Site 332, Moscow

150030

Yaroslavl Clinical Site 331, Yaroslavl

420103

Kazan Clinical Site 333, Kazan'

428007

Kaluga Clinical Site 328, Kaluga

St. Petersburg Clinical Site 325, Saint Petersburg

St. Petersburg Clinical Site 327, Saint Petersburg

443095

Samara Clinical Site 328, Samara

450005

Ufa Clinical Site 326, Ufa

454136

Chelyabinsk Clinical Site 322, Chelyabinsk

603155

Nizhniy Novgorod Clinical Site 321, Nizhny Novgorod

630091

Novosibirsk Clinical Site 324, Novosibirsk

06824

Fairfield Clinical Site 110, Fairfield

03756

Lebanon Clinical Site 115, Lebanon

Unknown

Gatineau Clinical Site 114, Gatineau

Kanto Region Clinical Site 404, Kanto

Kanto Region Clinical Site 405, Kanto

Kanto Region Clinical Site 406, Kanto

Kanto Region Clinical Site 409, Kanto

Kinki Region Clinical Site 401, Kinki

Kinki Region Clinical Site 407, Kinki

Kinki Region Clinical Site 408, Kinki

Tohoku Region Clinical Site 403, Tōhoku

Tohoku Region Clinical Site 410, Tōhoku

J4V2J2

Greenfield Park Clinical Site 109, Greenfield Park

V6T 2B5

Vancouver Clinical Site 131, British Columbia

H1T 2M4

Montreal Clinical Site 113, Québec

H9X 3Z9

Montreal Clinical Site 102, Québec

775 20

Olomouc Clinical Site 212, Olomouc

702 00

Ostrava Clinical Site 214, Ostrava

532 03

Pardubice Clinical Site 211, Pardubice

150 06

Praha 5 Clinical Site 213, Prague

04103

Leipzig Clinical Site 229, Leipzig

15-402

Bialystok Clinical Site 305, Bialystok

41-250

Czeladz Clinical Site 303, Czeladź

80-803

Gdansk Clinical Site 302, Gdansk

40-594

Katowice Clinical Site 309, Katowice

31-530

Krakow Clinical Site 307, Krakow

90-153

Lodz Clinical Site 306, Lodz

62-064

Plewiska Clinical Site 304, Plewiska

04-749

Warszawa Clinical Site 308, Warsaw

08025

Barcelona Clinical Site 252, Barcelona

Barcelona Clinical Site 253, Barcelona

08907

Hospitalet de Llobregat Clinical Site 251, L'Hospitalet de Llobregat

83000-490

Donetsk Clinical Site 345, Donetsk

03110

Kyiv Clinical Site 344, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ono Pharma USA Inc

INDUSTRY